![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 15, 14649-14655, April 9, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


¶
From the
¶Institute of Biochemistry, National Yang-Ming University, Taipei 112, Taiwan and
Graduate Institute of Microbiology, College of Medicine and ||Department of Medical Genetics, National Taiwan University, Taipei 100, Taiwan
The c-myc proto-oncogene encodes a ubiquitous transcription factor involved in the control of cell growth and differentiation and implicated in inducing tumorigenesis. Understanding the function of c-Myc and its role in cancer depends upon the identification of c-Myc target genes. Heat shock protein 90 (HSP90) is involved in the folding of proteins such as signal transduction molecules (Src, Raf1, cdk4) and steroid receptors and in enhancing the activity of telomerase and nitric-oxide synthase. Here we show that c-Myc directly activates HSP90A transcription. c-Myc-mediated induction of HSP90A transcription occurs in different tissues, is independent of cell proliferation, and is mediated by a c-Myc binding site in the proximal promoter region of HSP90A gene. Overexpression of HSP90A in Rat1a cells induces transformation. Short interference RNA of HSP90A/Hsp86
reduces transformation activity in HeLa and RatMyc cells. These results indicate that by induction of HSP90A c-Myc may control the activity of multiple signal pathways involved in cellular transformation.
Received for publication, August 11, 2003 , and in revised form, January 5, 2004.
* This work was supported in part by National Science Council Grants NSC 91-2320-B-002-070 and NSC 92-2320-B-010-078 (to K.-J. W.) and NSC 90-2311-B-002-073 (to S.-C. T.) and by National Health Research Institutes Grant NHRI-EX93-9329SI (to K.-J. W.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Contributed equally to the work.
** To whom correspondence should be addressed. Tel.: 11886-228267328; Fax: 11886-228202449; E-mail: kjwu2{at}ym.edu.tw.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. Faingold, J.-C. Marshall, E. Antecka, S. Di Cesare, A. N. Odashiro, S. Bakalian, B. F. Fernandes, and M. N. Burnier Jr. Immune Expression and Inhibition of Heat Shock Protein 90 in Uveal Melanoma Clin. Cancer Res., February 1, 2008; 14(3): 847 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maloney, P. A. Clarke, S. Naaby-Hansen, R. Stein, J.-O. Koopman, A. Akpan, A. Yang, M. Zvelebil, R. Cramer, L. Stimson, et al. Gene and Protein Expression Profiling of Human Ovarian Cancer Cells Treated with the Heat Shock Protein 90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Cancer Res., April 1, 2007; 67(7): 3239 - 3253. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schmitt, M. Gehrmann, M. Brunet, G. Multhoff, and C. Garrido Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy J. Leukoc. Biol., January 1, 2007; 81(1): 15 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G ELKAHLOUN, J. F POWERS, A. NYSKA, G. EISENHOFER, and A. S TISCHLER Gene expression profiling of rat pheochromocytoma. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 290 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Srirangam, R. Mitra, M. Wang, J. C. Gorski, S. Badve, L. Baldridge, J. Hamilton, H. Kishimoto, J. Hawes, L. Li, et al. Effects of HIV Protease Inhibitor Ritonavir on Akt-Regulated Cell Proliferation in Breast Cancer Clin. Cancer Res., March 15, 2006; 12(6): 1883 - 1896. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yang, H. Shi, R. Qi, S. Sun, Y. Tang, B. Zhang, and C. Wang Hsp90 Regulates Activation of Interferon Regulatory Factor 3 and TBK-1 Stabilization in Sendai Virus-infected Cells Mol. Biol. Cell, March 1, 2006; 17(3): 1461 - 1471. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jia, M. Takahashi, H. Morimoto, S. Takahashi, A. Izawa, H. Ise, T. Iwasaki, H. Hattori, K.-J. Wu, and U. Ikeda Changes in cardiac lipid metabolism during sepsis: The essential role of very low-density lipoprotein receptors Cardiovasc Res, February 1, 2006; 69(2): 545 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Rogulski, D. E. Cohen, D. L. Corcoran, P. V. Benos, and E. V. Prochownik Deregulation of common genes by c-Myc and its direct target, MT-MC1 PNAS, December 27, 2005; 102(52): 18968 - 18973. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-y. Zhang, L. M. DeSalle, J. H. Patel, A. J. Capobianco, D. Yu, A. Thomas-Tikhonenko, and S. B. McMahon Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein PNAS, September 27, 2005; 102(39): 13968 - 13973. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |